FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1554820472> ?p ?o ?g. }

• W1554820472 endingPage "550" @default.
• W1554820472 startingPage "543" @default.
• W1554820472 abstract "Aliment Pharmacol Ther 2010; 32: 543–550 Summary Background Portal vein tumour thrombosis is a negative prognostic factor for hepatocellular carcinoma (HCC). Aim To assess the efficacy of cisplatin in lipiodol emulsion combined with 5‐fluorouracil (5‐FU) for patients with HCC and portal vein tumour thrombosis. Methods The study subjects were 51 patients with the above‐specified criteria who received injection of cisplatin suspension in lipiodol emulsion followed by intra‐arterial infusion of 5‐FU. The primary objective was to determine tumour response to the treatment, while the secondary objectives were safety and tolerability. Independent factors for survival were also assessed. Results Ten patients had complete response and 34 patients had partial response (response rate, 86.3%). The median survival for all 51 patients was 33 months, while that for 10 complete response patients and 21 patients who showed disappearance of HCC following additional therapies was 39 months. The single factor that significantly influenced survival was therapeutic effect. Treatment was well tolerated and severe toxicity was infrequent, with only grade 3 toxicity (thrombocytopenia) in one patient. Conclusions The present study demonstrated the efficacy of hepatic arterial infusion chemotherapy using cisplatin‐lipiodol emulsion and 5‐FU without serious adverse effects in patients with unresectable HCC and portal vein tumour thrombosis." @default.
• W1554820472 created "2016-06-24" @default.
• W1554820472 creator A5013194037 @default.
• W1554820472 creator A5022560202 @default.
• W1554820472 creator A5023823880 @default.
• W1554820472 creator A5023934573 @default.
• W1554820472 creator A5037450420 @default.
• W1554820472 creator A5074132164 @default.
• W1554820472 creator A5084794851 @default.
• W1554820472 creator A5084839932 @default.
• W1554820472 date "2010-07-14" @default.
• W1554820472 modified "2023-10-17" @default.
• W1554820472 title "Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis" @default.
• W1554820472 cites W1604740730 @default.
• W1554820472 cites W1964042756 @default.
• W1554820472 cites W1971837077 @default.
• W1554820472 cites W1975154077 @default.
• W1554820472 cites W1990199684 @default.
• W1554820472 cites W1994193851 @default.
• W1554820472 cites W1998417832 @default.
• W1554820472 cites W2015674331 @default.
• W1554820472 cites W2016018273 @default.
• W1554820472 cites W2016770806 @default.
• W1554820472 cites W2020215421 @default.
• W1554820472 cites W2020830322 @default.
• W1554820472 cites W2024802373 @default.
• W1554820472 cites W2032743024 @default.
• W1554820472 cites W2034613825 @default.
• W1554820472 cites W2046626495 @default.
• W1554820472 cites W2049806901 @default.
• W1554820472 cites W2049812177 @default.
• W1554820472 cites W2062128964 @default.
• W1554820472 cites W2076668534 @default.
• W1554820472 cites W2079190859 @default.
• W1554820472 cites W2079997492 @default.
• W1554820472 cites W2081222934 @default.
• W1554820472 cites W2081871084 @default.
• W1554820472 cites W2096797256 @default.
• W1554820472 cites W2099169332 @default.
• W1554820472 cites W2110940689 @default.
• W1554820472 cites W2139248078 @default.
• W1554820472 cites W2140765540 @default.
• W1554820472 cites W2150120414 @default.
• W1554820472 cites W2153935627 @default.
• W1554820472 cites W2163557371 @default.
• W1554820472 cites W4243625103 @default.
• W1554820472 doi "https://doi.org/10.1111/j.1365-2036.2010.04379.x" @default.
• W1554820472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20500734" @default.
• W1554820472 hasPublicationYear "2010" @default.
• W1554820472 type Work @default.
• W1554820472 sameAs 1554820472 @default.
• W1554820472 citedByCount "35" @default.
• W1554820472 countsByYear W15548204722012 @default.
• W1554820472 countsByYear W15548204722013 @default.
• W1554820472 countsByYear W15548204722014 @default.
• W1554820472 countsByYear W15548204722015 @default.
• W1554820472 countsByYear W15548204722016 @default.
• W1554820472 countsByYear W15548204722017 @default.
• W1554820472 countsByYear W15548204722018 @default.
• W1554820472 countsByYear W15548204722019 @default.
• W1554820472 countsByYear W15548204722020 @default.
• W1554820472 countsByYear W15548204722021 @default.
• W1554820472 countsByYear W15548204722022 @default.
• W1554820472 countsByYear W15548204722023 @default.
• W1554820472 crossrefType "journal-article" @default.
• W1554820472 hasAuthorship W1554820472A5013194037 @default.
• W1554820472 hasAuthorship W1554820472A5022560202 @default.
• W1554820472 hasAuthorship W1554820472A5023823880 @default.
• W1554820472 hasAuthorship W1554820472A5023934573 @default.
• W1554820472 hasAuthorship W1554820472A5037450420 @default.
• W1554820472 hasAuthorship W1554820472A5074132164 @default.
• W1554820472 hasAuthorship W1554820472A5084794851 @default.
• W1554820472 hasAuthorship W1554820472A5084839932 @default.
• W1554820472 hasBestOaLocation W15548204721 @default.
• W1554820472 hasConcept C126322002 @default.
• W1554820472 hasConcept C141071460 @default.
• W1554820472 hasConcept C197934379 @default.
• W1554820472 hasConcept C2776694085 @default.
• W1554820472 hasConcept C2777546739 @default.
• W1554820472 hasConcept C2778019345 @default.
• W1554820472 hasConcept C2778239845 @default.
• W1554820472 hasConcept C2778375690 @default.
• W1554820472 hasConcept C2778448856 @default.
• W1554820472 hasConcept C2778800853 @default.
• W1554820472 hasConcept C2780456651 @default.
• W1554820472 hasConcept C2780868729 @default.
• W1554820472 hasConcept C71924100 @default.
• W1554820472 hasConcept C90924648 @default.
• W1554820472 hasConceptScore W1554820472C126322002 @default.
• W1554820472 hasConceptScore W1554820472C141071460 @default.
• W1554820472 hasConceptScore W1554820472C197934379 @default.
• W1554820472 hasConceptScore W1554820472C2776694085 @default.
• W1554820472 hasConceptScore W1554820472C2777546739 @default.
• W1554820472 hasConceptScore W1554820472C2778019345 @default.
• W1554820472 hasConceptScore W1554820472C2778239845 @default.
• W1554820472 hasConceptScore W1554820472C2778375690 @default.
• W1554820472 hasConceptScore W1554820472C2778448856 @default.
• W1554820472 hasConceptScore W1554820472C2778800853 @default.

• next